Suchergebnisse - "Hellmann, Matthew D"

PubPharm (215)

1

Efficacy of PD-(L)1 blockade monotherapy compared to PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: A cohort study

enthalten in: bioRxiv.org | 2024

von Elkrief, A. | Victor Alessi, J. | Ricciuti, B. | +18

2

Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation

enthalten in: Cancer immunology research | 2024

von Elkrief, A. | Waters, N. | Smith, N. | +26

3

Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer

enthalten in: Cancer cell | 2024

von Memon, D. | Schoenfeld, A. | Ye, D. | +30

4

Phase 1/2 study of monalizumab plus durvalumab in patients with advanced solid tumors

enthalten in: Journal for immunotherapy of cancer | 2024

von Patel, S. | Alonso-Gordoa, T. | Banerjee, S. | +11

5

Outcomes of Combination Platinum-Doublet Chemotherapy and Anti-PD(L)-1 Blockade in KRASG12C-Mutant Non-Small Cell Lung Cancer

enthalten in: The oncologist | 2023

von Elkrief, A. | Riccuiti, B. | Alessi, J. | +18

ErratumIn: Oncologist. 2024 Jan 5;29(1):e166. - PMID 38000087

6

Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Thummalapalli, R. | Ricciuti, B. | Bandlamudi, C. | +25

7

Clinical Benefit From Immunotherapy in Patients With SCLC Is Associated With Tumor Capacity for Antigen Presentation

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Rudin, C. | Balli, D. | Lai, W. | +10

CommentIn: J Thorac Oncol. 2023 Sep;18(9):1114-1117. - PMID 37599042

8

Somatic Mutations and Neoepitope Homology in Melanomas Treated with CTLA-4 Blockade

enthalten in: bioRxiv.org | 2023

von Nathanson, T. | Ahuja, A. | Rubinsteyn, A. | +8

9

Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas : a cohort study

enthalten in: Journal for immunotherapy of cancer | 2023

von Elkrief, A. | Alessi, J. | Ricciuti, B. | +18

10

Biomarker-directed, pembrolizumab-based combination therapy in non-small cell lung cancer : phase 2 KEYNOTE-495/KeyImPaCT trial interim results

enthalten in: Nature medicine | 2023

von Gutierrez, M. | Lam, W. | Hellmann, M. | +21

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[22]